Inflammation in end-stage renal disease--what have we learned in 10 years?
Carrero
Juan J
JJ
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Stenvinkel
Peter
P
D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D007249:Inflammation / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D018836:Inflammation Mediators / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000150:complications*; D011379:Prognosis; D011502:Protein-Energy Malnutrition / Q000209:etiology; D006435:Renal Dialysis; D012307:Risk Factors; D014511:Uremia / Q000150:complications
D018836:Inflammation Mediators